Streamline Health Solutions (STRM)
(Delayed Data from NSDQ)
$2.28 USD
+0.12 (5.56%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $2.25 -0.03 (-1.32%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMStreamline Health Solutions, Inc. (STRM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$14.99 | $14.99 | $14.99 | 593.98% |
Price Target
Only one analyst offered a short-term price target of $14.99 for Streamline Health Solutions, Inc. This represents an increase of 593.98% from the last closing price of $2.16.
Analyst Price Targets (1 )
Broker Rating
Streamline Health Solutions, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, two are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/5/2024 | Craig-Hallum | Matthew G Hewitt | Not Available | Strong Buy |
2/15/2024 | Lake Street Capital Markets | Brooks G O'Neil | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 2 |
Average Target Price | $14.99 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 66 of 252 |
Current Quarter EPS Est: | NA |